pyridostigmine bromide

Generic: pyridostigmine bromide

Labeler: amneal pharmaceuticals of new york llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name pyridostigmine bromide
Generic Name pyridostigmine bromide
Labeler amneal pharmaceuticals of new york llc
Dosage Form TABLET
Routes
ORAL
Active Ingredients

pyridostigmine bromide 30 mg/1

Manufacturer
Amneal Pharmaceuticals of New York LLC

Identifiers & Regulatory

Product NDC 0115-2134
Product ID 0115-2134_83d6b85c-0cd0-467c-90aa-6998f5302559
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA040502
Listing Expiration 2026-12-31
Marketing Start 2022-08-08

Pharmacologic Class

Classes
cholinesterase inhibitor [epc] cholinesterase inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 01152134
Hyphenated Format 0115-2134

Supplemental Identifiers

RxCUI
903841
UPC
0301152134019
UNII
KVI301NA53

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name pyridostigmine bromide (source: ndc)
Generic Name pyridostigmine bromide (source: ndc)
Application Number ANDA040502 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 30 mg/1
source: ndc
Packaging
  • 21 TABLET in 1 BOTTLE (0115-2134-01)
source: ndc

Packages (1)

0115-2134-01 21 TABLET in 1 BOTTLE (0115-2134-01)

Ingredients (1)

pyridostigmine bromide (30 mg/1)

Linked Drug Pages (1)

Pyridostigmine Bromide ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "83d6b85c-0cd0-467c-90aa-6998f5302559", "openfda": {"upc": ["0301152134019"], "unii": ["KVI301NA53"], "rxcui": ["903841"], "spl_set_id": ["91ca7bcf-d2cc-4cb3-bfbe-c294fd707524"], "manufacturer_name": ["Amneal Pharmaceuticals of New York LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "21 TABLET in 1 BOTTLE (0115-2134-01)", "package_ndc": "0115-2134-01", "marketing_start_date": "20220808"}], "brand_name": "Pyridostigmine Bromide", "product_id": "0115-2134_83d6b85c-0cd0-467c-90aa-6998f5302559", "dosage_form": "TABLET", "pharm_class": ["Cholinesterase Inhibitor [EPC]", "Cholinesterase Inhibitors [MoA]"], "product_ndc": "0115-2134", "generic_name": "PYRIDOSTIGMINE BROMIDE", "labeler_name": "Amneal Pharmaceuticals of New York LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Pyridostigmine Bromide", "active_ingredients": [{"name": "PYRIDOSTIGMINE BROMIDE", "strength": "30 mg/1"}], "application_number": "ANDA040502", "marketing_category": "ANDA", "marketing_start_date": "20220808", "listing_expiration_date": "20261231"}